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Domoic acid (DA) is a neuroexcitatory amino acid that is produced by Pseudo-nitzschia during harmful algal blooms (HAB). 
Accumulation of DA can be transferred through food chain and cause neuronal damage in marine animal and in human. Like oth-
er algal toxins, DA was suggested to increase the oxidative stress and increase the detoxification-related gene expression in fish. 
The widely used food antioxidant, tert-butylhydroquinone (tBHQ), was known to induce a wide range of antioxidative potentials 
such as elevation of the glutathione levels and glutathione S-transferases (GSTs), via the activation of antioxidant response ele-
ments (AREs). In this study, the influences of dietary tBHQ on domoic acid (DA) metabolism and detoxification-related gene 
transcription were investigated both in vivo and in vitro. Oral administration of tBHQ resulted in significant decreases of DA ac-
cumulation of liver tissues in which red sea bream were fed with a single dose of 10 mg DA and 100 mg tBHQ per kg body 
weight per fish. Real-time PCR further revealed that the mRNA levels of AHR/ARNT/CYP1A1/GSTA1/GSTR were up-regulated in 
the above liver tissues at 72 h post tBHQ treatment. In consistence, tBHQ exposure also resulted in increased mRNA transcription 
of GSTA1, GSTA2 and GSTR in cultured red sea bream hepatocytes. Collectively, our findings in this research suggested that the 
dietary intake of tBHQ accelerated DA metabolism in fish, through mechanisms involving altered transcription of detoxification- 
related liver genes.  
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Domoic acid is an excitatory neurotoxin produced by ma-
rine diatoms of the genus Pseudo-nitzschia. It is responsible 
for a neurotoxic disease called amnesic shellfish poisoning 
(ASP) in human and marine mammals following consump-
tion of DA (domoic acid)-contaminated fish. Symptoms of 
ASP include short-term memory loss, brain damage and 
death in severe cases. During harmful algal blooms, accu-
mulation of high concentration of DA has been reported for 
a number of marine species such as types of cockles (Ce-
rastoderma edule), crabs (Cancer magister), furrow shell 
(Scrobicularia plana), mussels (Mytilus edulis), razor clams 
(Siliqua patula) and scallops (Pecten maximus) [1–3]. Other 
fish species, such as anchovies and mackerel, have also 
been shown to accumulate DA, although at much lower 
levels compared with those found in shellfish [3]. A major-
ity of DA uptake was excreted via kidney and bile in fish, 
with the remaining absorbed DA mainly detected in liver, 
heart, spleen and muscle [4]. Limited data was available on 
in vivo metabolism in fish, although previous studies sug-
gested that the biotransformation and detoxification path-
ways of Phase I and/or Phase II xenobiotic metabolism en-
zymes (XMEs) were involved in DA metabolism [5]. Fur-
ther investigations using intraperitoneal (I.P.) injection of 
DA in fish revealed that a receptor-mediated induction of 
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phase I XMEs cytochrome P-450 1A1 (CYP1A1) gene ex-
pression was involved in the biotransformation and detoxi-
fication of DA [6,7].  
tert-Butylhydroquinone (tBHQ) is an phenolic antioxi-
dant that is widely used as a food-additive. Dietary intake of 
tBHQ was shown to alter the activities of the endogenous 
antioxidant enzymes through activation of Nrf2 in both 
mammals and fish. Induction of a wide range of antioxida-
tive potentials such as elevation of the glutathione levels 
and GSTs, via the activation of ARE, was believed to be 
responsible for the protective effect of tBHQ [8]. Further-
more, Gharavi and El-Kadi [9], and Schreiber et al. [10] 
demonstrated that tBHQ could also induce Phase I XMEs, 
cytochrome P450 1A1 (CYP1A1) gene expression directly 
in an aryl hydrocarbon receptor (AHR)-dependent manner 
in murine and human hepatoma cells. However, only lim-
ited information is available about the potential influence of 
tBHQ on DA metabolism in fish. Red sea bream Pagrus 
major is a commercial carnivorous fish breeding in the sea 
water of the east coast of China, which is inevitably pollut-
ed with DA during harmful algal blooms. In this study, we 
evaluated the effect of tBHQ on DA metabolism and detox-
ification-related gene transcription both in vivo and in vitro. 
The results could contribute to a better understanding of the 
molecular basis for DA detoxification, and bring new in-
sights into the DA metabolism mechanism in fish.  
1  Materials and methods  
1.1  Toxin and reagents 
Domoic acid (DA) and tert-butylhydroquinone (tBHQ) were 
purchased from BBI (Markham, Ontario, Canada) and Sig-
ma (St. Louis, MO, USA), respectively. All the primers 
used in this research were synthesized by Sangon (Shanghai, 
China). 
1.2  Hepatocyte isolation and tBHQ treatment 
Red sea bream Pagrus major (body weight about 500 g per 
fish) were obtained from Zhangpu fish farm (Fujian Prov-
ince, China). Fish were then killed by a sharp blow on the 
head and livers were pooled individually. After extensive 
wash to eliminate as much blood as possible, hepatocytes 
were isolated by 0.25% trypsin digestion at 28°C for 40 min. 
Cells were suspended in Hanks buffer and washed with the 
same medium for three times. Isolated hepatocytes were 
maintained in 6-well petri dishes (~1.12×107 cells mL1) in 
DMEM containing 100 IU mL1 penicillin, 100 g mL1 
streptomycin and 5% fetal bovine serum and cultured at 
28°C, supplied with 5% CO2. The cells were then exposed 
to 40 mol L1 or 60 mol L1 tBHQ or media only (control 
treatment) for 24 h [11]. Every treatment was repeated four 
times. The number of cells was counted and cell viability 
was determined for each sample using Trypan blue exclusion 
at each time point before quantification of gene expression. 
1.3  Rearing of red sea bream Pagrus major and expo-
sure scenario 
Red sea bream Pagrus major (16.92±4.28 g) were obtained 
from Zhangpu fish farm (Fujian Province, China). Fish were 
maintained in aquariums with continuous system of sea wa-
ter filtration and aeration at constant temperature (26±2°C). 
Fish were fed with commercial fish diet at a rate of 2% of 
body weight twice (9:00 and 15:00) a day. 
The red sea bream (n=20) were fasted for 24 h before 
oral gavaging of 10 mg kg1 body weight (bwt) of DA and 
100 mg kg1 bwt tBHQ (within 200 L total volume, mixed 
in semi-liquid feed of ground frozen fish and shrimp) using 
16# bulb-tipped gavage needles [11]. The control fish were 
fed with tBHQ-free diet containing DA only. The fish were 
maintained in the above mentioned aquaria system. At each 
time point, five fish in each group were sacrificed at 24 and 
72 h post treatment and the liver tissues were collected, re-
spectively. The amount of DA in the liver tissues was de-
termined. 
1.4  Total RNA isolation from red sea bream hepato-
cytes and liver tissues 
Total RNA was isolated from cultured hepatocytes or liver 
tissues using SV Total RNA Isolation System (Promega, 
USA), as described in the manufacturer’s instruction. The 
extracted RNA was resuspended in 50 L RNase-free water 
and quantified using Eppendorf Biophotometer (Germany). 
Samples were stored at 80°C before use. 
1.5  Quantification of the mRNA of AHR, ARNT, 
CYP1A1, GSTA1, GSTA2, GSTR and HSP70 by Real- 
Time PCR 
The relative mRNA levels of AHR, ARNT, CYP1A1, GSTA1, 
GSTA2, GSTR, Hsp70 and beta-actin in the hepatocytes and 
liver tissues of red sea bream were determined by RT-PCR. 
Gene-specific primers were designed with the Primer De-
signer Software 2.0, based on the cDNA sequences in the 
GenBank (Accession Nos. AB197788, FJ231886, EU107275, 
AB158410, AB158411, AB158412, AY190703, and 
AY190686, respectively). The sequences of the gene-spe-     
cific primers and the sizes of PCR products are shown in 
Table 1. Beta-actin was amplified in parallel as an internal 
control. Reverse transcription was performed with oli-
go(dT)20 primer using First Strand cDNA Synthesis Kit 
(Toyobo, Japan). The SYBR® Premix Ex TaqTM Kit 
(TaKaRa, Japan) was used for Real-Time PCR on a Chromo4 
Real-Time Detection System (MJ Research, Hercules, CA, 
USA) according to the manufacture’s instructions. Each PCR 
reaction consisted of 10 L 2× SYBR Mix, 0.4 mol L1 
forward primer, 0.4 mol L1 reverse primer, cDNA equivalent 
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Table 1  The sequences of primers for Real-Time PCR in red sea bream Pagrus major 
Name of primer Sequence of primer (GenBank accession Nos.) Size of PCR product (bp) 
FQ-PM-AHR01F 5′-CTATTCTCCATTGCTATGC-3′ (AB197788) 200 
FQ-PM-AHR02R 5′-ATCATATCAGCTGCATGG-3′ (AB197788)  
FQ-PM-ARNT01F 5′-GGAGTATCATTAACAGACG-3′ (FJ231886) 187 
FQ-PM-ARNT02R 5′-TGCAGCGGTGGTCTATGA-3′ (FJ231886)  
FQ-PM-CYP1A01F 5′-ATGAGAACTCCAATGTCCA-3′ (EU107275) 197 
FQ-PM-CYP1A02R 5′-AAGGGTAAGTTGGGTTT-3′ (EU107275)  
FQ-PM-GSTA101F 5′-GCTACCTTCCAGTGTTCG-3′ (AB158410) 199 
FQ-PM-GSTA102R 5′-TTCAGGAACTCGTCGATG-3′ (AB158410)  
FQ-PM-GSTA201F 5′-TGGAATCCTTGGCGACTT-3′ (AB158411) 196 
FQ-PM-GSTA202R 5′-GTGAGGAGTGTACCAGAAC-3′ (AB158411)  
FQ-PM-GSTR01F 5′-CTGGCTGATGTGTGTGTT-3′ (AB158412) 203 
FQ-PM-GSTR02R 5′-TGTTCCAGTGTGTCAGCATC-3′ (AB158412)  
FQ-PM-HSP7001F 5′-ACCTCTTCCGTGGCACCTT-3′ (AY190703) 195 
FQ-PM-HSP7002R 5′-CTCCGTAGGCCACAGCTTCAT-3′ (AY190703)  
FQ-PM-ACT01F 5′-AATCGCCGCACTGGTTGTTG-3′ (AY190686) 217 
FQ-PM-ACT02R 5′-CACAATACCGTGCTCGAT-3′ (AY190686)  
 
to that generated from 1 g total RNA. ddH2O was used to 
adjust the total volume of each reaction to 20 L. Melting 
curve analysis of PCR products was performed at the end of 
each PCR reaction to confirm the specificity. For every 
sample, quantitative PCR was performed three times. PCR 
settings for all reactions were 95°C for 3 min, followed by 
45 cycles at 95°C for 20 s, 57°C for 20 s, 72°C for 35 s. 
Having confirmed the amplification efficiency of each tar-
get gene, the relative quantifications of target gene expres-
sion were calculated with the delta Ct method using the Op-
ticon Monitor software 2.03 Version (MJ research, USA). 
The relative mRNA levels of liver GSTs were expressed as 
the ratio of GSTs/beta-actin (%).  
1.6  DA extraction and quantification by ELISA 
Fresh red sea bream liver samples (1 g) were ground by 
sonication. Homogenates were extracted twice with 100% 
methanol for 30 min with sufficient mixing using a magnetic 
stirrer, followed by centrifugation at 4000 r min1 for 10 min. 
The supernatant was concentrated on Sep-pak C18 cartridge 
(Waters), which was pre-washed with 100% methanol and 
water. The cartridge was then rinsed with 25 mL 20% 
methanol and was eluted with 5 mL 100% methanol. The 
elusions were air-dried and re-dissolved in 0.5 mL of 100% 
methanol:water (1:1, v/v). DA concentrations in these 
samples were quantified by immunoassay using EIA Do-
moic 2 h Kit (Groupe, Belgium). Triplicates of DA stand-
ards of six different concentrations and triplicates of each 
sample were included in each microtiter plate for measuring 
(TECAN Infinite 200, Austria). A standard curve was con-
structed and the average value of each triplicated samples 
was recorded for further analysis (Magellan software V 5.03).  
1.7  Statistical analysis 
Statistical analysis was performed with SPSS13.0 software. 
Significant differences were found by using one-way analy-
sis of variance (ANOVA), followed by the post hoc test, 
after checking for data normality and homogeneity of vari-
ances. Differences were considered to be significant if P< 
0.05. Values were expressed as means±S.E. (n=5) for each 
group.  
2  Results 
2.1  The influences of tBHQ on the mRNA expression 
of AHR, ARNT, CYP1A1, GSTA1, GSTA2, GSTR and 
HSP70 in cultured hepatocytes 
Due to the antioxidative potentials of tBHQ, the transcrip-
tion of the endogenous antioxidant enzymes including AHR, 
ARNT, CYP1A1, GSTA1, GSTA2, GSTR and HSP70 was 
analyzed in cultured hepatocytes. Slight decrease of cell 
numbers was observed in the cultured red sea bream hepato-
cytes when exposed to tBHQ. The cell viabilities were 
maintained 96% throughout the experiment in both control 
cells and cells exposed to tBHQ. Compared with that in the 
control cells, tBHQ treatment, at both 40 and 60 mol L1, 
significantly induced GSTs transcription in hepatocytes. 
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The mRNA levels of GSTA1, GSTA2 and GSTR were up- 
regulated by 1.22, 1.33 and 1.09-fold on 40 mol L1 tBHQ 
and by 1.13, 1.28 and 1.58 fold on 60 mol L1 tBHQ, re-
spectively. The expression of AHR was also slightly in-
duced by tBHQ treatment. However, no further induction 
was observed with tBHQ treatment at higher concentration. 
In contrast, the transcription of CYP1A1 was slightly de-
creased in cultured hepatocytes that treated with 40 mol 
L1 tBHQ and was dramatic decreased (P<0.05) in cultured 
hepatocytes treated with 60 mol L1 tBHQ. The influences 
of tBHQ on the transcription of ARNT and Hsp70 were 
debatable, with controversial results obtained in cultured 
hepatocytes treated with tBHQ treatment at different con-
centrations (Figure 1).  
2.2  The influences of tBHQ on AHR, ARNT, CYP1A1, 
GSTA1, GSTA2, GSTR and HSP70 transcription in vivo 
Due to the critical roles GSTs play in DA detoxification and 
the significantly increased GSTs expression in cells exposed 
to tBHQ in vitro, the influences of tBHQ on mRNA expres-
sion of GSTs in the liver tissues of the red sea bream previ-
ously exposed to DA were determined using real-time PCR. 
Compared with others, the mRNA levels of AHR and ARNT 
were extremely low and were not presented in the same 
figure. The results showed that compared with the control 
group, oral gavaging tBHQ resulted in dramatic increase, 
about 2.87-fold, in the relative mRNA level of GSTA2 in the 
liver tissue of the red sea bream 24 h after fed with tBHQ 
(Figure 2). However, no significant difference was observed 
on the GSTA2 mRNA level between the control fish and the 
tBHQ fed fish at 72 h after DA treatment. In contrast, the  
 
Figure 1  The influences of tBHQ on detoxification-related gene tran-
scription in vitro. The relative mRNA abundance of AHR, ARNT, CYP1A, 
GSTA1, GSTA2, GSTR and HSP70 in cultured red sea bream Pagrus major 
hepatocytes was determined by Real-Time PCR after exposure to 0, 40 and 
60 mol L1 tBHQ for 24 h. The level of AHR was too low to be presented 
in the same figure, although slight induction of expression by tBHQ treat-
ment was also observed. Columns represent the means of four repeats of 
each sample. Bars represent the standard errors. Significant changes 
(P<0.05) were found by using one-way analysis of variance (ANOVA), 
followed by the post hoc test, after checking for data normality and homo-
geneity of variances, and were indicated with stars (*).  
 
Figure 2  The influences of tBHQ on detoxification-related gene tran-
scription in vivo. The relative mRNA abundance of AHR, ARNT, CYP1A, 
GSTA1, GSTA2, GSTR and HSP70 in red sea bream Pagrus major liver 
tissues were determined by Real-Time PCR at 24 and 72 h after oral ad-
ministration of 10 mg kg1 DA and 100 mg kg1 tBHQ. The mRNA levels 
of AHR and ARNT were very low and not presented in the same figure, 
while significant increases of their transcription were also observed at 72 h 
post tBHQ treatment. Columns represent the means of the data obtained in 
five fish for each treatment. Bars represent the standard errors. Significant 
changes (P<0.05) were found by using one-way analysis of variance 
(ANOVA), followed by the post hoc test, after checking for data normality 
and homogeneity of variances, and were indicated with stars (*). 
mRNA levels of liver AHR, ARNT, CYP1A1, GSTA1 and 
GSTR were barely affected at 24 h after tBHQ treatment, 
although were significantly increased by 3.21, 1.94, 7.18, 
5.17 and 30.21-fold, respectively, at 72 h after oral admin-
istration of tBHQ (P<0.05) (Figure 2). No detectable change 
was observed for HSP70 mRNA transcription in fish liver at 
both time points. The fluctuation of these gene transcription 
might reflect the process of DA metabolism and excretion 
in the liver of red sea bream. 
2.3  The influence of tBHQ on the accumulation of DA 
in liver tissues 
A single dose of 2% of body weight commercial feed con-
taining 10 mg kg1 body weight (bwt) of DA and 100 mg 
kg1 bwt tBHQ per fish was used to feed each red sea bream 
that had fasted for 24 h. The control fish were fed with 
tBHQ free diet containing DA only. Throughout the entire 
observation period of experiment, the liver tissues of red sea 
bream displayed unnoticeable pathological changes in re-
gard to the shape and the color. Neither liver bleeding nor 
edema was observed with naked eyes in those fish by the 
time of sacrificing. The concentrations of DA in the liver 
tissues of red sea bream at 24 and 72 h after oral administra-
tion of tBHQ were shown in Figure 3. At 24 h post tBHQ 
treatment (accumulation period), the concentration of DA in 
liver tissues of the treatment group was 16.79±6.91 ng g1 
tissue, much lower than that of the control group (66.17± 
29.60 ng g1 tissue) (P<0.05). However, at 72 h after oral 
administration of tBHQ (depuration period), the DA con-
centration in liver tissues of control group decreased dra-
matically (4.48±3.90 ng g1 tissue) and no significant dif-
ference in DA accumulation in liver was observed between  
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Figure 3  The effect of tBHQ on DA accumulation in liver. The DA 
concentrations in the liver tissues of red sea bream Pagrus major were 
determined at different time points after oral administration of 10 mg kg1 
DA and 100 mg kg1 tBHQ. Columns represent the means of the data ob-
tained in five fish for each treatment. Bars represent the standard errors. 
Significant changes (P<0.05) were found by using one-way analysis of 
variance (ANOVA), followed by the post hoc test, after checking for data 
normality and homogeneity of variances, and were indicated with stars (*). 
the control group and the tBHQ treated group (3.90±1.71   
ng g1 tissue). 
3  Discussion 
Harmful algal blooms are globally increasing natural events 
and may cause sub-lethal effects such as increased stress 
behaviour, including lowered spontaneous activity, loss of 
appetite and reduced overall growth in human following 
consumption of contaminated seafood. Domoic acid is a 
water-soluble amino acid produced by Pseudo-nitzschia during 
HAB and causes excitoxicity/death in neuron cells by bind-
ing glutamate receptor irreversibly in both marine animals 
and human. It was shown in previous studies that short term 
toxin exposure reduced survival of larval fish [12]. In fish, 
orally administered DA could be absorbed from GI track 
and absorbed DA could be detected in plasma and various 
tissues within 15 min after DA exposure [13,14]. Absorbed 
DA was largely excreted via kidney and bile in the first 
72–96 h, with remaining DA subjected to biotransformation 
to less toxic derivatives, a process yet to be clarified. For 
instance, like other algal toxins, DA increased oxidative 
stress and the activities of liver detoxification enzymes, 
including GPx, CAT and SOD in fish [15]. 
Previous studies showed that tBHQ could induce Phase II 
XMEs and exhibited anticarcinogenic effects in human and 
rat cells [16,17]. Exposure to tBHQ was shown to trigger 
the accumulation of nuclear factor erythroid 2-related factor 
2 (Nrf2) in nuclear, where they could form heterodimers 
with other transcription factors, such as Jun and small Maf 
[18]. These heterodimers could then bind the AREs of the 
5′-regulatory region of several Phase II detoxification genes, 
including GSTs, and then activate the GSTs gene expres-
sion [19–22]. Our results in this study showed that tBHQ  
exposure significantly induced the transcription of detoxifi-
cation-related genes in red sea bream hepatocytes using 
Real-Time PCR. The mRNA levels of GSTA1, GSTA2 and 
GSTR were increased after tBHQ exposure in hepatocytes 
both in vitro and in vivo, indicating a role in inducing Phase 
II XMEs for tBHQ in red sea bream. It was in consistent 
with the proposed antioxidant protective role for tBHQ in 
fish [23]. In addition, Poulson et al. [24] had characterized a 
functional XRE and an ARE in rat GSTA2 and their prox-
imity. Human GSTA1 and GSTA2 could be induced by 
AHR agonists in human hepatocyte cultures of some indi-
viduals [25,26]. Further studies are needed to determine 
whether the induced expression of Phase II XMEs (GSTA1, 
GSTA2 and GSTR) by tBHQ in red sea bream hepatocytes 
are due to multiple mechanisms linking AHR- and Nrf2- 
induced batteries [27].  
The mRNA expression levels of AHR and ARNT were 
significantly increased in the red sea bream liver tissues at 
72 h after oral administration of tBHQ. Not only Phase I 
genes (AHR and ARNT) but also Phase II genes (GSTA1, 
GSTA2 and GSTR) expression levels were induced signifi-
cantly by tBHQ in red sea bream liver tissues, indicating 
that the metabolic adaptation of tBHQ might be coordinately 
regulated by a set of phases I and II XMEs. Further char-     
acterization of the response elements such as XREs and 
AREs in the regulatory region of these target genes may 
provide a genetic basis to understand AHR- and Nrf2-in-     
duced genes. The effect of tBHQ on Phase I XME expres-
sion, CYP1A, needs further investigation since controver-
sial results were obtained in cultured hepatocytes and in 
liver tissues in vivo. We further investigated the potential 
influence of tBHQ on DA metabolism in red sea bream in 
vivo. A single dose of approximately 10 mg DA kg1 fish 
was used for oral gavage, representing the environmentally 
relevant daily maximum dose of DA. No signs of neural 
toxicity and death were observed in our experimental fish. 
Comparing with the DA accumulation (66.17±29.60 ng g1 
tissue) in liver tissues of control group, tBHQ exposure sig-
nificantly decreased DA accumulation (16.79±6.91 ng g1) 
within 24 h after tBHQ treatment. The results indicated that 
dietary intake of tBHQ could effectively stimulate the first 
phase of DA excretion in red sea bream liver, which could 
be the consequence of the elevated Phase II XMEs gene 
expression. However, no obvious difference in the DA con-
centration in liver tissues was observed between tBHQ 
treated fish and the control fish at 72 h after oral administra-
tion of tBHQ. It suggested that tBHQ may have very limited 
influence on the second phase of DA elimination.  
In conclusion, our results in this study suggested that di-
etary intake of tBHQ can effectively stimulate DA metabo-
lism, possibly by increasing the transcription of detoxifica-
tion-related liver genes in fish. The metabolic adaptation 
may be consequences of coordinately regulated phases I and 
II XMEs. 
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